Preferences for potential benefits and risks for gene therapy in the treatment of sickle cell disease.
Gonzalez Sepulveda JM, Yang JC, Reed SD, Lee TH, Ng X, Stothers S, Irony T, Ho M, Rothman JA, Badawy S, Rowley C, Little J, Shah NR, Li K, Telen MJ.
Gonzalez Sepulveda JM, et al. Among authors: yang jc.
Blood Adv. 2023 Dec 12;7(23):7371-7381. doi: 10.1182/bloodadvances.2023009680.
Blood Adv. 2023.
PMID: 37905989
Free PMC article.